Monday, October 26, 2026 · Daily editionET --:--:--

Finished

Rehabilitation Robotic System ReHand

NCT06937346 · Karaganda Medical University · Updated 5 Aug 2025

What is being tested
The Rehand Robotic Glove; Standard Rehabilitation
For
Stroke; Rehabilitation; Robotic Exoskeleton
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 18 years to 74 years. About 120 people. The full rules are on the registry page.
Where
Kazakhstan
When
Starts or started 1 March 2024, ends 30 May 2025. Registered 22 April 2025.
Results
Posted on the registry on 5 Aug 2025.

In the researchers' words

The aim of this clinical trial is to investigate the efficacy of the ReHand rehabilitation system for the recovery of patients after a stroke. The main objectives of the study: 1. To assess the functional state of patients with cerebral stroke according to the The Barthel Index, on the Functional Independence Measure (FIM) scale of functional independence. 2. To assess the neurological deficit of patients according to the National Institutes of Health Stroke Scale (NIHSS), the state of function of the affected arm and the degree of fine motor impairment according to the The Frenchay Arm Test (FAT), The Fugl-Meyer Assessment for upper extremity (FMA-UE) scale, modified Wolf Motor Function Test (mWMFT), according to the upper limb disability questionnaire The Disabilities of the Arm, Shoulder, and Hand (DASH) test. 3. To investigate the state of psycho-emotional status in patients on the Hospital Anxiety and Depression Scale (HADS) of anxiety and depression. 4. To determine the effectiveness of the rehabilitation performed in patients with cerebral stroke after recovery by the ReHand system according to the above scales. Participants: All patients received standard rehabilitation methods according to the clinical protocol for diagnosis and treatment No. 94, "The third stage of medical rehabilitation", approved by the Joint Commission on the Quality of Medical Services of the…
ClinicalTrials.gov, NCT06937346

Sites

  • Karaganda regionKaraganda, Kazakhstan